Summitry LLC lifted its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 14.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,855 shares of the company’s stock after buying an additional 5,877 shares during the quarter. Summitry LLC’s holdings in Procter & Gamble were worth $7,465,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of PG. Brighton Jones LLC increased its position in Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares during the period. Taylor Financial Group Inc. increased its stake in Procter & Gamble by 10.6% during the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after acquiring an additional 277 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Procter & Gamble in the first quarter valued at $228,000. Formidable Asset Management LLC raised its stake in shares of Procter & Gamble by 0.3% in the 1st quarter. Formidable Asset Management LLC now owns 293,368 shares of the company’s stock valued at $49,996,000 after buying an additional 963 shares in the last quarter. Finally, Buckhead Capital Management LLC lifted its stake in Procter & Gamble by 4.7% during the first quarter. Buckhead Capital Management LLC now owns 5,816 shares of the company’s stock worth $991,000 after purchasing an additional 263 shares during the period. 65.77% of the stock is owned by institutional investors.
Analyst Ratings Changes
PG has been the topic of several recent analyst reports. Dbs Bank raised Procter & Gamble to a “moderate buy” rating in a report on Tuesday, October 28th. Raymond James Financial reduced their target price on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. UBS Group lowered their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Finally, Morgan Stanley set a $175.00 price target on Procter & Gamble in a research note on Monday, October 27th. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $171.53.
Procter & Gamble Stock Down 0.2%
NYSE:PG opened at $147.71 on Friday. Procter & Gamble Company has a 1 year low of $144.09 and a 1 year high of $180.43. The stock has a 50-day moving average price of $151.83 and a two-hundred day moving average price of $156.57. The stock has a market cap of $345.16 billion, a price-to-earnings ratio of 21.56, a PEG ratio of 3.87 and a beta of 0.36. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same quarter in the previous year, the business posted $1.93 EPS. Procter & Gamble’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio is currently 61.61%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Balaji Purushothaman sold 490 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider directly owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Matthew W. Janzaruk sold 725 shares of the stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares of the company’s stock, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 150,489 shares of company stock valued at $23,529,864 over the last quarter. 0.20% of the stock is currently owned by corporate insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What is the Nasdaq? Complete Overview with History
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Short Selling – The Pros and Cons
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
